The mega-trial now named OCTOPUS will be delivered by Professors Jeremy Chataway (Chief Investigator, UCL Queen Square Institute of Neurology) and Mahesh Parmar (Director of the MRC Clinical Trials Unit, Faculty of Population Health Sciences) alongside the UK MS society. After a number of years of planning, the ambition to speed up clinical trials for progressive MS has become ...
Here you can find all the latest news from the MRC CTU at UCL.
ODYSSEY trial finds new drug is better for treating children living with HIV
The anti-HIV drug Dolutegravir improves outcomes for children with HIV infection, when given in a 3-drug anti-HIV combination. These results come from the ODYSSEY trial which was presented yesterday at the Conference on Retroviruses and Opportunistic Infections. Dolutegravir has a number of potential advantages, including: Few drug-to-drug interactions, making it easier to ...
Men who have had surgery for early stage testicular cancer can avoid potentially harmful scans.
Tribute to Professor James Hakim
PediCAP recruits its first participant